Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Takeda logo — Better Health, Brighter Future

Takeda

Better Health, Brighter Future

Founded 1781 Japan Japan 37130 employees IPO Total: $57.80M Biotechnology, Pharmaceutical

General Information

Company Name Takeda
Founded Year 1781
Location Japan Japan
Employees 37130
Industries Biotechnology, Pharmaceutical
Funding Stage IPO
Business Model B2B, B2C, B2G
Revenue Model Product Sales, Licensing, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Takeda. To contact Takeda, visit takeda.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Takeda compare?

A PDF of Takeda and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Takeda soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Takeda

Takeda, headquartered in Japan, is a historic player in the Biotechnology and Pharmaceutical industries, embodying more than two centuries of commitment to patient-centric healthcare solutions. Their slogan, "Better Health, Brighter Future," reflects their enduring mission to transform lives by prioritizing what truly matters to patients and redefining standards within the healthcare system.

Founded in 1781, Takeda stands out for its adaptive approach to scientific advancements, consistently pushing boundaries to address evolving healthcare needs. Their recent financial activities include a Post IPO Debt investment on 01 April 2024, indicating solid investor confidence in their strategic direction and financial health.

For investors, Takeda presents a unique blend of tradition and innovation, as they leverage their long-standing values to navigate modern challenges and seize emerging opportunities within the global healthcare landscape.

Business keywords: transformative healthcare, patient-centered approach, innovative medicine, pharmaceutical research, healthcare solutions, values-driven, scientific advancement, societal impact, health system collaboration, patient advocacy, medical breakthroughs, lifesaving treatments

Services & Products

Drug Development
Clinical Trials
Manufacturing
Corporate Governance
Ethics and Transparency

Target Customers

Patients with Chronic Diseases Healthcare Providers Investors Global Healthcare Markets

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt Undisclosed -
01 Apr 2024
Grant $19.80M 1
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation
01 Sep 2016
Grant $38.00M 1
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation
01 May 2016

Latest News

View All
JPM25, Day 1: GSK's billion-dollar bet, Bayer's trial first, Lilly buys Scorpion, and more — Fiercebiotech.com
JPM25, Day 1: GSK's billion-dollar bet, Bayer's trial first, Lilly buys Scorpion, and more
Fiercebiotech.com Jan 13, 2025

Takeda Alternatives & Competitors

View All Alternatives
Takeda vs
BridgeBio
BridgeBio United States

We move at the speed of patient need.

Post-IPO Equity
875 employees
Biotechnology, Health Care
Takeda vs
Novo Nordisk
Novo Nordisk Denmark

We’re here to champion long-term health. Get updates on innovation and inspiring stories 💙

IPO
62491 employees
Biotechnology, Pharmaceutical
Takeda vs
Jazz Pharmaceuticals
Jazz Pharmaceuticals Ireland

Identifying, developing and commercializing meaningful products that address unmet medical needs

IPO
3640 employees
Biotechnology, Health Care
View all alternatives

FAQ About Takeda

Better Health, Brighter Future
Takeda was founded in 1781.
Takeda is headquartered in Japan.
Takeda operates in Biotechnology and Pharmaceutical. Its work centres on transformative healthcare, patient-centered approach, innovative medicine and pharmaceutical research. Its customers include Patients with Chronic Diseases, Healthcare Providers and Investors.
Takeda has a B2B, B2C and B2G business model. Its revenue comes from Product Sales, Licensing and Service Fee.
Takeda has approximately 37130 employees.
Takeda has completed 3 funding rounds, raising a total of $57.80M. The latest funding stage is IPO.
Takeda offers: Drug Development, Clinical Trials, Manufacturing, Corporate Governance, Ethics and Transparency.
Top alternatives and competitors to Takeda include BridgeBio, Novo Nordisk, Jazz Pharmaceuticals, Yaqrit, EUSA Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Takeda and BridgeBio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Takeda, https://bouncewatch.com/company/takeda, updated 24 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout